end of September, we had cash and cash equivalents of $23,400,000 compared with $26,900,000 on December 31, 2023. Net inventories on September 30 were $59,900,000 down 16.9% compared to September 30, 2023 and down 10.5% compared to December 31, 2023 as we continue to manage our inventories more efficiently. Now as we head into the final quarter of the year, we expect to continue focusing on cost management and operational efficiencies. We are carefully managing our restructuring initiatives to ensure long term profitability, while maintaining our focus on delivering innovative products and enhancing our premium positioning in the market. As Rob discussed in his remarks, for the full year, we expect to be at the lower end of our guidance range for revenue of $490,000,000 to $510,000,000 and also at the lower end of our guidance range for adjusted EBITDA of negative $20,000,000 to negative $10,000,000 Despite the macroeconomic pressures, we remain confident in our ability to execute our path to premium sleep strategy over the longer term and deliver sustained profitability over time.